Results 261 to 270 of about 5,850,068 (304)
Some of the next articles are maybe not open access.
Atherosclerotic Cardiovascular Disease in Diabetes Patients
Current Diabetes Reviews, 2023Background: Diabetes mellitus (DM) is a metabolic disorder characterized by abnormally elevated levels of blood glucose. The hyperglycemic condition is caused by abnormalities in either insulin secretion, insulin action, or both. Two-thirds of diabetes-related deaths are caused by atherosclerotic cardiovascular disease (ASCVD).
Rina Amelia +3 more
openaire +2 more sources
Colchicine in atherosclerotic cardiovascular disease
HeartInflammation has a direct role in the development of atherosclerotic vascular disease, and oral colchicine displays broad anti-inflammatory properties. Several large, randomised controlled trials (RCTs) have evaluated colchicine’s impact on cardiovascular outcomes.
Bradley Tucker +3 more
openaire +2 more sources
Atherosclerotic cardiovascular disease in rheumatoid arthritis
Current Rheumatology Reports, 2003The past 3 years have seen a remarkable growth in the interest of cardiovascular disease in rheumatoid arthritis. There have been studies published documenting an increased incidence and prevalence of cardiovascular conditions in patients with rheumatoid arthritis compared with individuals without rheumatoid arthritis.
Inmaculada, del Rincón +1 more
openaire +2 more sources
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design, 2023Abstract: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a novel class of hypolipidemic drugs, providing an additional therapeutic option over conventional hypolipidemic treatments. Given the constantly lowering recommended LDL-C goals, low goal achievement rate and low compliance with treatment, new hypolipidemic drug ...
Dimitrios, Delialis +8 more
openaire +2 more sources
Chelation therapy for atherosclerotic cardiovascular disease
Cochrane Database of Systematic Reviews, 2002Chelation therapy is being promoted and practiced all over the world as a form of alternative medicine in the treatment of atherosclerotic cardiovascular disease. It has been recommended as a safe, relatively inexpensive and non-surgical method of restoring blood flow in atherosclerotic vessels.
M V, Villarruz, A, Dans, F, Tan
openaire +2 more sources
Ascorbic Acid and Atherosclerotic Cardiovascular Disease
1996In this chapter, we have briefly reviewed the current scientific knowledge of the role of vitamin C in the prevention of atherosclerosis and its associated clinical manifestations. There is good evidence from animal studies that vitamin C can slow the progression of experimental atherosclerosis.
S M, Lynch, J M, Gaziano, B, Frei
openaire +2 more sources
Sleep calibrates atherosclerotic cardiovascular disease
Nature Cardiovascular Research, 2022Sleep modulates cardiovascular health, and recent studies have begun to uncover underlying mechanistic links. An integrated translational approach that combines animal models and human trials will enrich scientific discovery, improve therapy, and help to alleviate the global burden of insufficient sleep and cardiovascular disease.
Oren Cohen +2 more
openaire +2 more sources
Prevention of Atherosclerotic Cardiovascular Disease in Childhood
Current Cardiology Reports, 2020Atherosclerotic-CVD processes begin early in life and are influenced over the life course by interaction of genetic and potential modifiable risk factors, behaviors, and environmental exposures. The purpose of this review is to highlight importance of primordial and primary prevention beginning early in the life course.Evidence-based guidelines and ...
openaire +2 more sources
Haematometabolism rewiring in atherosclerotic cardiovascular disease
Nature Reviews CardiologyAtherosclerotic cardiovascular diseases are the most frequent cause of death worldwide. The clinical complications of atherosclerosis are closely linked to the haematopoietic and immune systems, which maintain homeostatic functions and vital processes in the body.
Yvan-Charvet, Laurent +2 more
openaire +3 more sources
Effect of niacin on atherosclerotic cardiovascular disease
The American Journal of Cardiology, 1998Niacin has been studied in 6 major clinical trials with cardiovascular endpoints. The Coronary Drug Project (CDP) was the largest of these trials and the only one to use niacin monotherapy affecting cardiovascular outcomes: recurrent myocardial infarction and cerebrovascular events were significantly decreased.
openaire +2 more sources